LY86

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, LY86 mutation is significantly associated with the RNA expression of many other genes, with 342 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible LY86-associated genes across cancer lineages are RNA5SP65, TRIM39-RPP21, and OR7E125P. Each is linked with LY86 in more than 1 cancer types. Because this analysis shows association rather than direction, both LY86-to-partner and partner-to-LY86 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA5SP65 grouped by LY86-low versus LY86-high in LUAD.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LY86→partner) and Y-score (partner→LY86) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADRNA5SP65 →+0.745+4.888<.001.00532
UCECTRIM39-RPP21 →+0.122+3.133<.001.00232
BRCAOR7E125P →+0.026+8.057<.001.00531
BRCARNA5SP335 →+0.419+5.230<.001.00731
BRCALINC00474 →+0.121+5.409<.001.00531
BRCAMIR147A →+0.566+4.995.002.00931
Each partner links to its Q-omics profile. Showing the 6 strongest of 342 associations by consensus.

RNA5SP65 by LY86 expression — LUAD

Box plot of RNA5SP65 in LY86-low vs LY86-high samples in LUAD.

Explore this box plot interactively →

Exploration